Search Results - "Khraishi, Majed"
-
1
Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics
Published in Journal of the American Academy of Dermatology (01-11-2013)“…Background Prompt identification and treatment of psoriatic arthritis (PsA) in patients with psoriasis is critical to reducing the risk of joint damage,…”
Get full text
Journal Article -
2
Canadian Adalimumab Postmarketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (COMPLETE-PsA): 12-month Results of Comparative Effectiveness of Adalimumab and nbDMARDs
Published in Journal of rheumatology (01-05-2022)“…COMPLETE-PsA was an observational study of biologic-naïve Canadian adults with active psoriatic arthritis (PsA) treated with adalimumab (ADA) or a nonbiologic…”
Get full text
Journal Article -
3
Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics
Published in Journal of the American Academy of Dermatology (01-10-2014)“…Background General practitioners/dermatologists may be aware of musculoskeletal symptoms in patients with psoriasis but may have difficulty accurately…”
Get full text
Journal Article -
4
CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides
Published in Journal of rheumatology (01-01-2016)“…The Canadian Vasculitis research network (CanVasc) is composed of physicians from different medical specialties and researchers with expertise in vasculitis…”
Get full text
Journal Article -
5
Biosimilars: A Multidisciplinary Perspective
Published in Clinical therapeutics (01-05-2016)“…Abstract A biosimilar is an officially regulated and approved copy of an originator biologic therapy. Improved affordability and consequent wider patient…”
Get full text
Journal Article -
6
Experience with subcutaneous abatacept for rheumatoid arthritis: an update for clinicians
Published in Therapeutic Advances in Musculoskeletal Disease (01-10-2014)“…Abatacept is recommended by several expert consensus groups including the 2013 update of the EULAR recommendations for the pharmacologic management of…”
Get full text
Book Review Journal Article -
7
Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry
Published in BMJ open (13-08-2020)“…ObjectivesThe objectives of this study were to describe the demographic profile and baseline disease characteristics of patients with psoriatic arthritis (PsA)…”
Get full text
Journal Article -
8
Tofacitinib Safety and Effectiveness in Canadian Patients with Rheumatoid Arthritis by Cardiovascular Risk Enrichment: Subanalysis of the CANTORAL Study
Published in Rheumatology and therapy. (01-12-2024)“…Introduction ORAL Surveillance, a post-authorisation safety study of patients with rheumatoid arthritis (RA) enriched for cardiovascular (CV) risk,…”
Get full text
Journal Article -
9
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice
Published in Journal of rheumatology (01-04-2017)“…To develop preliminary treat-to-target (T2T) recommendations for psoriasis and psoriatic arthritis (PsA) for Canadian daily practice. A task force composed of…”
Get full text
Journal Article -
10
Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study
Published in Therapeutic advances in musculoskeletal disease (01-01-2019)“…Background: The aim of this study was to assess the real-world effectiveness and safety of certolizumab pegol (CZP) in rheumatoid arthritis (RA) patients, and…”
Get full text
Journal Article -
11
Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis
Published in Pediatric rheumatology online journal (10-09-2019)“…In adult patients with arthritis, use of the tumor necrosis factor (TNF) inhibitor etanercept (ETN) is often associated with a reduction in the utilization of…”
Get full text
Journal Article -
12
Effectiveness and Safety of Infliximab in Rheumatoid Arthritis: Analysis From a Canadian Multicenter Prospective Observational Registry
Published in Arthritis care & research (2010) (01-08-2014)“…Objective To describe the profile of rheumatoid arthritis (RA) patients treated with infliximab in Canadian routine care and to assess the real‐world…”
Get full text
Journal Article -
13
Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study
Published in Rheumatology and therapy. (01-12-2018)“…Introduction This study was conducted to observe patterns of use of the interleukin-6 receptor-alpha inhibitor tocilizumab in routine clinical practice in…”
Get full text
Journal Article -
14
Safety profile of abatacept in rheumatoid arthritis: A review
Published in Clinical therapeutics (01-10-2010)“…Abstract Background: Abatacept, a soluble human fusion protein that selectively modulates the costimulatory signal required for full T-cell activation, is…”
Get full text
Journal Article -
15
Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis
Published in BMJ open (05-04-2016)“…ObjectivesTo describe the profile of patients with ankylosing spondylitis (AS) treated with infliximab in Canadian routine care and to assess the effectiveness…”
Get full text
Journal Article -
16
CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody (ANCA)-Associated Vasculitides – Executive Summary
Published in Canadian Journal of Kidney Health and Disease (2015)“…The Canadian Vasculitis research network (CanVasc) is composed of physicians from different medical specialties, including rheumatology and nephrology and…”
Get full text
Book Review Journal Article -
17
Elevated serum nitric oxide levels in patients with inflammatory arthritis associated with co-expression of inducible nitric oxide synthase and protein kinase C-eta in peripheral blood monocyte-derived macrophages
Published in Journal of rheumatology (01-12-2003)“…OBJECTIVE: To quantify circulating nitric oxide (NO) levels and inducible NO synthase (iNOS) expression in peripheral blood monocyte-derived macrophages…”
Get full text
Journal Article -
18
Real-World Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results From the Canadian Spondyloarthritis Research Network
Published in Journal of rheumatology (01-05-2023)“…Axial spondyloarthritis (axSpA) is a chronic, immune-mediated, inflammatory condition consisting of 2 clinical subsets: nonradiographic axSpA and ankylosing…”
Get full text
Journal Article -
19
Real-World Retention and Clinical Effectiveness of Secukinumab for Psoriatic Arthritis: Results From the Canadian Spondyloarthritis Research Network
Published in Journal of rheumatology (01-05-2023)“…Psoriatic arthritis (PsA) is an immune-mediated disease characterized by pain, stiffness, and swelling of peripheral joints, with an estimated prevalence in…”
Get full text
Journal Article -
20
Comparative overview of safety of the biologics in rheumatoid arthritis
Published in Journal of rheumatology. Supplement (01-06-2009)“…Six biologic agents are currently available in Canada for the treatment of rheumatoid arthritis (RA): abatacept, adalimumab, anakinra, etanercept, infliximab,…”
Get more information
Journal Article